Georgios Arampatzis

Dr. Georgios Arampatzis


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JZJulija Zavadlav
Julija Zavadlav
GAGeorgios Arampatzis
Georgios Arampatzis
PKPetros Koumoutsakos
Petros Koumoutsakos
The necessity for accurate and computationally efficient representations of water in atomistic simulations that can span biologically relevant timescales has born the necessity of coarse-grained (CG) modeling. Despite numerous advances, CG water models rely mostly on a-priori specified assumptions. How these assumptions affect the model accuracy, efficiency, and in particular transferability, has not been systematically investigated. Here we propose a data driven comparison and selection for CG water models through a Hierarchical Bayesian framework. We examine CG water models that differ in their level of coarse-graining, structure, and number of interaction sites. We find that the importance of electrostatic interactions for the physical system under consideration is a dominant criterion for the model selection. Multi-site models are favored, unless the effects of water in electrostatic screening are not relevant, in which case the single site model is preferred due to its computational savings. The charge distribution is found to play an important role in the multi-site model’s accuracy while the flexibility of the bonds/angles may only slightly improve the models. Furthermore, we find significant variations in the computational cost of these models. We present a data informed rationale for the selection of CG water models and provide guidance for future water model designs.

31 July 2023 in Computer Methods in Applied Mechanics and Engineering
Verified
Journal Article
Closed access
IKIvica Kičić
Ivica Kičić
PVPantelis R. Vlachas
Pantelis R. Vlachas
GAGeorgios Arampatzis
Georgios Arampatzis
MCMichail Chatzimanolakis
Michail Chatzimanolakis
LGLeonidas Guibas
Leonidas Guibas
PKPetros Koumoutsakos
Petros Koumoutsakos

23 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
PKPetr Karnakov
Petr Karnakov
GAGeorgios Arampatzis
Georgios Arampatzis
IKIvica Kičić
Ivica Kičić
FWFabian Wermelinger
Fabian Wermelinger
DWDaniel Wälchli
Daniel Wälchli
PKPetros Koumoutsakos
Petros Koumoutsakos
The reproduction number (R0) is broadly considered as a key indicator for the spreading of the COVID-19 pandemic. The estimation of its value with respect to the key threshold of 1.0 is a measure of the need, and eventually effectiveness, of interventions imposed in various countries. Here we present an online tool for the data driven inference and quantification of uncertainties for R0 as well as the time points of interventions for 51 European countries. The study relies on the Bayesian calibration of the simple and well established SIR model with data from reported daily infections. The model is able to fit the data for most countries without individual tuning of parameters. We deploy an open source Bayesian inference framework and efficient sampling algorithms to present a publicly available GUI (https://www.cse-lab.ethz.ch/coronavirus/) that allows the user to assess custom data and compare predictions for pairs of European countries. The results provide a ranking based on the rate of the disease's spread suggesting a metric for the effectiveness of social distancing measures. They also serve to demonstrate how geographic proximity and related times of interventions can lead to similarities in the progression of the epidemic.

19 August 2020 in medRxiv
Verified
Preprint
Open access
PDF file
NBNikola Biller-Andorno
Nikola Biller-Andorno
AFAndrea Ferrario
Andrea Ferrario
SJSusanne Joebges
Susanne Joebges
TKTanja Krones
Tanja Krones
FMFederico Massini
Federico Massini
MKMichael Krauthammer
Michael Krauthammer
Artificial intelligence (AI) systems are increasingly being used in healthcare, thanks to the high level of performance that these systems have proven to deliver. So far, clinical applications have focused on diagnosis and on prediction of outcomes. It is less clear in what way AI can or should support complex clinical decisions that crucially depend on patient preferences. In this paper, we focus on the ethical questions arising from the design, development and deployment of AI systems to support decision-making around cardio-pulmonary resuscitation leading to the determination of a patient’s Do Not Attempt to Resuscitate (DNAR) status (also known as code status). The COVID-19 pandemic has made us keenly aware of the difficulties physicians encounter when they have to act quickly in stressful situations without knowing what their patient would have wanted. We discuss the results of an interview study conducted with healthcare professionals in a university hospital aimed at understanding the status quo of resuscitation decision processes while exploring a potential role for AI systems in decision-making around code status. Our data suggest that 1) current practices are fraught with challenges such as insufficient knowledge regarding patient preferences, time pressure and personal bias guiding care considerations and 2) there is considerable openness among clinicians to consider the use of AI-based decision support. We suggest a model for how AI can contribute to improve decision-making around resuscitation and propose a set of ethically relevant preconditions – conceptual, methodological and procedural – that need to be considered in further development and implementation efforts.

10 November 2020 in medRxiv
Verified
Preprint
Open access
PDF file
MCMichail Chatzimanolakis
Michail Chatzimanolakis
PWPascal Weber
Pascal Weber
GAGeorgios Arampatzis
Georgios Arampatzis
DWDaniel Wälchli
Daniel Wälchli
IKIvica Kičić
Ivica Kičić
PKPetros Koumoutsakos
Petros Koumoutsakos
The systematic identification of infected individuals is critical for the containment of the COVID-19 pandemic. Presently, the spread of the disease is mostly quantified by the reported numbers of infections, hospitalizations, recoveries and deaths; these quantities inform epidemiology models that provide forecasts for the spread of the epidemic and guide policy making. The veracity of these forecasts depends on the discrepancy between the numbers of reported and unreported, yet infectious, individuals. We combine Bayesian experimental design with an epidemiology model and propose a methodology for the optimal allocation of limited testing resources in space and time, which maximizes the information gain for such unreported infections. The proposed approach is applicable at the onset and spreading of the epidemic and can forewarn for a possible recurrence of the disease after relaxation of interventions. We examine its application in Switzerland; the open source software is, however, readily adaptable to countries around the world. We find that following the proposed methodology can lead to vastly less uncertain predictions for the spread of the disease. Estimates of the effective reproduction number and of the future number of unreported infections are improved, which in turn can provide timely and systematic guidance for the effective identification of infectious individuals and for decision-making.

26 July 2020 in medRxiv
Verified
Preprint
Open access
PDF file
MCMichail Chatzimanolakis
Michail Chatzimanolakis
PWPascal Weber
Pascal Weber
GAGeorgios Arampatzis
Georgios Arampatzis
DWDaniel Wälchli
Daniel Wälchli
IKIvica Kičić
Ivica Kičić
PKPetros Koumoutsakos
Petros Koumoutsakos
The systematic identification of infectious, yet unreported, individuals is critical for the containment of the COVID-19 pandemic. We present a strategy for identifying the location, timing and extent of testing that maximizes information gain for such infections. The optimal testing strategy relies on Bayesian experimental design and forecasting epidemic models that account for time dependent interventions. It is applicable at the onset and spreading of the epidemic and can forewarn for a possible recurrence of the disease after relaxation of interventions. We examine its application in Switzerland and show that it can provide timely and systematic guidance for the effective identification of infectious individuals with finite testing resources. The methodology and the open source code are readily adaptable to countries around the world. We present a strategy for the optimal allocation of testing resources in order to detect COVID-19 infections in a country’s population .